Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Enlivex Therapeutics Ltd (ENLV)

Enlivex Therapeutics Ltd (ENLV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 371,892
  • Shares Outstanding, K 10,114
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,240 K
  • 60-Month Beta 1.69
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 23.96

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.00 +53.21%
on 08/28/19
36.80 -0.08%
on 09/20/19
+8.57 (+30.39%)
since 08/20/19
3-Month
17.02 +116.04%
on 06/21/19
36.80 -0.08%
on 09/20/19
+19.00 (+106.92%)
since 06/20/19
52-Week
6.16 +496.92%
on 12/31/18
36.80 -0.08%
on 09/20/19
+26.37 (+253.56%)
since 09/20/18

Most Recent Stories

More News
New Patent Covering Enlivex's AllocetraTM Immunotherapy Was Allowed By The Israeli Patent Authority

Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the Israeli Patent Authority issued a notice of allowance for a patent application covering ALLOCETRA, the company's...

ENLV : 36.77 (+1.04%)
Enlivex Therapeutics To Present At The 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.

Enlivex Therapeutics Ltd. (Nasdaq:ENLV), a clinical-stage immunotherapy company, today announced that company management will make a corporate presentation at the 21st Annual Global Investment Conference,...

ENLV : 36.77 (+1.04%)
Enlivex Therapeutics Announces Positive Outcome From Safety Committee's Review Of Six Patients With Severe Sepsis Patients; Enrollment Of Last Study Cohort Approved

Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the safety review committee of the Company's ongoing Phase Ib clinical trial in patients with severe...

ENLV : 36.77 (+1.04%)
Immunotherapy Company Enlivex Announces Dual Listing on the Tel-Aviv Stock Exchange

The Company's shares, which currently trade on NASDAQ, will be dual-listed on the Tel Aviv Stock Exchange (TASE) starting on July 22, 2019, under the symbol ENLV

ENLV : 36.77 (+1.04%)
Enlivex Therapeutics Provides Clinical Update on Positive Safety Profile of Its Off-The-Shelf Cell Therapy Product in First Three Severe Sepsis Patients

Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today provided a clinical update on the positive safety profile of its off-the-shelf cell therapy, Allocetra, in the first...

ENLV : 36.77 (+1.04%)
IMMUNOTHERAPY COMPANY ENLIVEX THERAPEUTICS SELECTED TO RECEIVE AN ADDITIONAL $1 MILLION GRANT BY THE ISRAEL INNOVATION AUTHORITY FOR ITS SEPSIS CLINICAL PROGRAM

Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the Israel Innovation Authority (IIA) selected the Company's clinical program for prevention of cytokine...

ENLV : 36.77 (+1.04%)
IMMUNOTHERAPY COMPANY ENLIVEX THERAPEUTICS COMPLETES PREVIOUSLY ANNOUNCED FINANCING PRICED AT $12.25 PER SHARE, RAISING A TOTAL OF APPROXIMATELY $8.4 MILLION

Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced the final closing of a private placement financing of ordinary shares priced at $12.25 per share, raising...

ENLV : 36.77 (+1.04%)
ENLIVEX THERAPEUTICS TO PRESENT AT THE 2019 H.C. WAINWRIGHT GLOBAL LIFE SCIENCES CONFERENCE

Enlivex Therapeutics Ltd. (Nasdaq:ENLV), a clinical-stage immunotherapy company, today announced that company management will make a corporate presentation at the H.C. Wainwright Global Life Sciences 2019...

ENLV : 36.77 (+1.04%)
Immunotherapy Company Enlivex Therapeutics Announces Nasdaq Listing Under Symbol "ENLV" and Closing of Private Placement of Ordinary Shares Priced at $12.25 Per Share

Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced its Nasdaq listing under the symbol "ENLV" and the concurrent closing of a private placement of ordinary...

ENLV : 36.77 (+1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ENLV with:

Business Summary

Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome)...

See More

Key Turning Points

2nd Resistance Point 37.32
1st Resistance Point 37.05
Last Price 36.77
1st Support Level 36.25
2nd Support Level 35.72

See More

52-Week High 36.80
Last Price 36.77
Fibonacci 61.8% 25.10
Fibonacci 50% 21.48
Fibonacci 38.2% 17.86
52-Week Low 6.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar